+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Peripheral Vascular Devices Market 2021-2028

  • PDF Icon

    Report

  • 192 Pages
  • March 2021
  • Region: Global
  • Triton Market Research
  • ID: 5306568
According to the publisher, the global peripheral vascular devices market is expected to display a positive market trend over the estimated phase 2021-2028, while exhibiting a CAGR of 11.54%.



Factors such as the growing incidence of peripheral arterial disease (PAD) and the adoption of minimally-invasive procedures for its treatment are majorly boosting the growth of this market. However, the stringent regulatory processes and the intense rivalry among competitors are hampering the industry growth. On the bright side though, continuous advancement in technology presents numerous growth opportunities for the studied market. Also, developing nations are showing huge potential for growth, which is beneficial for market progress.

REGIONAL OUTLOOK

The global market for peripheral vascular devices spans across the regions of North America, the Asia-Pacific, Europe, Latin America, and the Middle East and Africa.
The Asia-Pacific is anticipated to showcase the fastest growth rate in the global market. Countries in this region offer lucrative opportunities for industry players. Also, factors such as increasing healthcare budgets and expanding disposable income are helping the market to grow further. Besides, a rise in the demand for advanced vascular devices, as a result of the rise in the geriatric population, is supplementing the growth of the peripheral vascular devices market.

COMPETITIVE OUTLOOK

The companies competing in the peripheral vascular devices market include Terumo Interventional Systems Inc, Boston Scientific Corporation, Angioscore Inc (Spectranetics Corporation), Becton Dickinson and Company, Cardinal Health Inc (Cordis), Teleflex Medical, Medtronic Plc, Koninklijke Philips NV, Cook Group, Endologix, Edwards Lifesciences Corporation, and Abbott Laboratories.
Cardinal Health Inc is a Fortune 500 company providing healthcare services. Its specialization includes the distribution of medical products and pharmaceuticals, and it serves more than 100,000 locations. Cardinal Health completed the acquisition of Cordis in 2015, which was earlier a subsidiary of Johnson & Johnson. The INCRAFT AAA Stent Graft System, PRECISE PRO RX Stent, ANGIOGUARD RX Guidewire System, CORDIS Access Portfolio Diagnostic Guidewires, EMERALD Diagnostic Guidewire, AQUATRACK Hydrophilic Nitinol Guidewire, Guiding Catheters, and Steerable Guidewires are some of the products and systems offered by the company. Cardinal's health brand products are sold and distributed across North America, Europe, Asia, and other regions.
Frequently Asked Questions about the Global Peripheral Vascular Devices Market

What is the estimated value of the Global Peripheral Vascular Devices Market?

The Global Peripheral Vascular Devices Market was estimated to be valued at $3451.66 million in 2021.

What is the growth rate of the Global Peripheral Vascular Devices Market?

The growth rate of the Global Peripheral Vascular Devices Market is 11.5%, with an estimated value of $7414.83 million by 2028.

What is the forecasted size of the Global Peripheral Vascular Devices Market?

The Global Peripheral Vascular Devices Market is estimated to be worth $7414.83 million by 2028.

Who are the key companies in the Global Peripheral Vascular Devices Market?

Key companies in the Global Peripheral Vascular Devices Market include Abbott Laboratories, Angioscore Inc (Spectranetics Corporation), Boston Scientific Corporation, Becton Dickinson and Company, Cook Group, Cardinal Health Inc (Cordis), Edwards Lifesciences Corporation, Endologix, Koninklijke Philips Nv and Medtronic plc.

Table of Contents

1. Global Peripheral Vascular Devices Market - Summary
2. Industry Outlook
2.1. Key Insights
2.1.1. Surge in the Adoption of Vascular Procedures
2.1.2. Product Recalls Owing to Safety Concerns
2.2. Impact of COVID-19 on Peripheral Vascular Devices Market
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Market Strategies
2.6.1. Merger & Acquisitions
2.6.2. Product Launch & Developments
2.6.3. Partnership, Contract/Agreement & Collaboration
2.6.4. Business Expansion
2.7. Market Drivers
2.7.1. Minimally-Invasive Procedures for Peripheral Arterial Disease
2.7.2. Proliferating Incidence of Peripheral Arterial Disease
2.7.3. Changing Lifestyle and Rapid Growth in Aging Population
2.7.4. Continuous Technological Advancements
2.8. Market Restraints
2.8.1. Stringent Regulatory Process
2.8.2. Lack of Proper Reimbursement Policies for Peripheral Vascular Devices
2.8.3. Intense Competition
2.9. Market Opportunities
2.9.1. Awareness Among Patients About Treatment Options
2.9.2. Market Potential in Developing Countries
3. Global Peripheral Vascular Devices Market Outlook – by Device Type
3.1. Peripheral Vascular Stents
3.1.1. Self-Expanding Peripheral Vascular Stents
3.1.2. Balloon-Expanding Peripheral Vascular Stents
3.1.3. Drug-Eluting Peripheral Vascular Stents
3.1.4. Covered Stents
3.2. Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters
3.2.1. Standard Pta Balloon Catheter
3.2.2. High-Pressure Pta Balloon Catheter
3.2.3. Large Pta Balloon Catheter
3.2.4. Small Pta Balloon Catheter
3.2.5. Specialty Pta Balloon Catheter
3.2.6. Drug-Coated Pta Balloon Catheter
3.3. Percutaneous Transluminal Angioplasty (Pta) Guidewires
3.4. Atherectomy Devices
3.5. Embolic Protection Devices
3.6. Inferior Vena Cava Filters
3.7. Other Device Types
4. Global Peripheral Vascular Devices Market – Regional Outlook
4.1. North America
4.1.1. Market by Device Type
4.1.1.1. Market by Peripheral Vascular Stents
4.1.1.2. Market by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters
4.1.2. Country Analysis
4.1.2.1. United States
4.1.2.2. Canada
4.2. Europe
4.2.1. Market by Device Type
4.2.1.1. Market by Peripheral Vascular Stents
4.2.1.2. Market by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters
4.2.2. Country Analysis
4.2.2.1. United Kingdom
4.2.2.2. Germany
4.2.2.3. France
4.2.2.4. Spain
4.2.2.5. Italy
4.2.2.6. Russia
4.2.2.7. Rest of Europe
4.3. Asia-Pacific
4.3.1. Market by Device Type
4.3.1.1. Market by Peripheral Vascular Stents
4.3.1.2. Market by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters
4.3.2. Country Analysis
4.3.2.1. China
4.3.2.2. Japan
4.3.2.3. India
4.3.2.4. South Korea
4.3.2.5. Asean Countries
4.3.2.6. Australia & New Zealand
4.3.2.7. Rest of Asia-Pacific
4.4. Latin America
4.4.1. Market by Device Type
4.4.1.1. Market by Peripheral Vascular Stents
4.4.1.2. Market by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters
4.4.2. Country Analysis
4.4.2.1. Brazil
4.4.2.2. Mexico
4.4.2.3. Rest of Latin America
4.5. Middle East and Africa
4.5.1. Market by Device Type
4.5.2. Market by Peripheral Vascular Stents
4.5.3. Market by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters
4.5.4. Country Analysis
4.5.4.1. United Arab Emirates
4.5.4.2. Turkey
4.5.4.3. Saudi Arabia
4.5.4.4. South Africa
4.5.4.5. Rest of Middle East & Africa
5. Competitive Landscape
5.1. Abbott Laboratories
5.2. Angioscore Inc (Spectranetics Corporation)
5.3. Boston Scientific Corporation
5.4. Becton Dickinson and Company
5.5. Cook Group
5.6. Cardinal Health Inc (Cordis)
5.7. Edwards Lifesciences Corporation
5.8. Endologix
5.9. Koninklijke Philips Nv
5.10. Medtronic plc
5.11. Teleflex Medical
5.12. Terumo Interventional Systems Inc
6. Methodology & Scope
6.1. Research Scope & Deliverables
6.2. Sources of Data
6.3. Research Methodology
List of Tables
Table 1: Global Peripheral Vascular Devices Market, Regional Outlook, 2021-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: List of Merger & Acquisitions
Table 5: List of Product Launch & Developments
Table 6: List of Partnership, Contract/Agreement & Collaboration
Table 7: List of Business Expansion
Table 8: Global Peripheral Vascular Devices Market, by Device Type, 2021-2028 (In $ Million)
Table 9: Global Peripheral Vascular Devices Market, by Geography, 2021-2028 (In $ Million)
Table 10: North America Peripheral Vascular Devices Market, by Country, 2021-2028 (In $ Million)
Table 11: North America Peripheral Vascular Devices Market, by Device Type, 2021-2028 (In $ Million)
Table 12: North America Peripheral Vascular Devices Market, by Peripheral Vascular Stents, 2021-2028 (In $ Million)
Table 13: North America Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters, 2021-2028 (In $ Million)
Table 14: Europe Peripheral Vascular Devices Market, by Country, 2021-2028 (In $ Million)
Table 15: Europe Peripheral Vascular Devices Market, by Device Type, 2021-2028 (In $ Million)
Table 16: Europe Peripheral Vascular Devices Market, by Peripheral Vascular Stents, 2021-2028 (In $ Million)
Table 17: Europe Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters, 2021-2028 (In $ Million)
Table 18: Asia-Pacific Peripheral Vascular Devices Market, by Country, 2021-2028 (In $ Million)
Table 19: Asia-Pacific Peripheral Vascular Devices Market, by Device Type, 2021-2028 (In $ Million)
Table 20: Asia-Pacific Peripheral Vascular Devices Market, by Peripheral Vascular Stents, 2021-2028 (In $ Million)
Table 21: Asia-Pacific Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters, 2021-2028 (In $ Million)
Table 22: Latin America Peripheral Vascular Devices Market, by Country, 2021-2028 (In $ Million)
Table 23: Latin America Peripheral Vascular Devices Market, by Device Type, 2021-2028 (In $ Million)
Table 24: Latin America Peripheral Vascular Devices Market, by Peripheral Vascular Stents, 2021-2028 (In $ Million)
Table 25: Latin America Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters, 2021-2028 (In $ Million)
Table 26: Middle East and Africa Peripheral Vascular Devices Market, by Country, 2021-2028 (In $ Million)
Table 27: Middle East and Africa Peripheral Vascular Devices Market, by Device Type, 2021-2028 (In $ Million)
Table 28: Middle East and Africa Peripheral Vascular Devices Market, by Peripheral Vascular Stents, 2021-2028 (In $ Million)
Table 29: Middle East and Africa Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters, 2021-2028 (In $ Million)
List of Figures
Figure 1: Porter's Five Forces Analysis
Figure 2: Global Peripheral Vascular Devices Market, by Device Type, 2020 & 2028
Figure 3: Global Peripheral Vascular Devices Market, by Peripheral Vascular Stents, 2021-2028 (In $ Million)
Figure 4: Global Peripheral Vascular Devices Market, by Peripheral Vascular Stents, 2020 & 2028
Figure 5: Global Peripheral Vascular Devices Market, by Self-Expanding Peripheral Vascular Stents, 2021-2028 (In $ Million)
Figure 6: Global Peripheral Vascular Devices Market, by Balloon-Expanding Peripheral Vascular Stents, 2021-2028 (In $ Million)
Figure 7: Global Peripheral Vascular Devices Market, by Drug-Eluting Peripheral Vascular Stents, 2021-2028 (In $ Million)
Figure 8: Global Peripheral Vascular Devices Market, by Covered Stent, 2021-2028 (In $ Million)
Figure 9: Global Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters, 2021-2028 (In $ Million)
Figure 10: Global Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Balloon Catheters, 2020 & 2028
Figure 11: Global Peripheral Vascular Devices Market, by Standard Pta Balloon Catheter, 2021-2028 (In $ Million)
Figure 12: Global Peripheral Vascular Devices Market, by High-Pressure Pta Balloon Catheter, 2021-2028 (In $ Million)
Figure 13: Global Peripheral Vascular Devices Market, by Large Pta Balloon Catheter, 2021-2028 (In $ Million)
Figure 14: Global Peripheral Vascular Devices Market, by Small Pta Balloon Catheter, 2021-2028 (In $ Million)
Figure 15: Global Peripheral Vascular Devices Market, by Specialty Pta Balloon Catheter, 2021-2028 (In $ Million)
Figure 16: Global Peripheral Vascular Devices Market, by Drug-Coated Pta Balloon Catheter, 2021-2028 (In $ Million)
Figure 17: Global Peripheral Vascular Devices Market, by Percutaneous Transluminal Angioplasty (Pta) Guidewires, 2021-2028 (In $ Million)
Figure 18: Global Peripheral Vascular Devices Market, by Atherectomy Devices, 2021-2028 (In $ Million)
Figure 19: Global Peripheral Vascular Devices Market, by Embolic Protection Devices, 2021-2028 (In $ Million)
Figure 20: Global Peripheral Vascular Devices Market, by Inferior Vena Cava Filters, 2021-2028 (In $ Million)
Figure 21: Global Peripheral Vascular Devices Market, by Other Device Types, 2021-2028 (In $ Million)
Figure 22: Global Peripheral Vascular Devices Market, Regional Outlook, 2019 & 2028 (In %)
Figure 23: United States Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 24: Canada Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 25: United Kingdom Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 26: Germany Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 27: France Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 28: Spain Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 29: Italy Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 30: Russia Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 31: Rest of Europe Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 32: China Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 33: Japan Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 34: India Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 35: South Korea Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 36: Asean Countries Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 37: Australia & New Zealand Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 38: Rest of Asia-Pacific Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 39: Brazil Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 40: Mexico Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 41: Rest of Latin America Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 42: United Arab Emirates Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 43: Turkey Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 44: Saudi Arabia Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 45: South Africa Peripheral Vascular Devices Market 2021-2028 (In $ Million)
Figure 46: Rest of Middle East & Africa Peripheral Vascular Devices Market 2021-2028 (In $ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Angioscore Inc (Spectranetics Corporation)
  • Boston Scientific Corporation
  • Becton Dickinson and Company
  • Cook Group
  • Cardinal Health Inc (Cordis)
  • Edwards Lifesciences Corporation
  • Endologix
  • Koninklijke Philips Nv
  • Medtronic plc
  • Teleflex Medical
  • Terumo Interventional Systems Inc